Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials ('Scope or cope' and 'Scope or cope II') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.

Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.

Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.

獸醫(yī)微生物學(xué)研究的是家養(yǎng)脊椎動(dòng)物（家畜、伴侶動(dòng)物、毛皮動(dòng)物、野味、家禽、魚類）的微生物（細(xì)菌、真菌、病毒）疾病，這些動(dòng)物提供食物、其他有用產(chǎn)品或陪伴。此外，如果感染與人類（人畜共患?。┖?或家畜有相互關(guān)系，則圈養(yǎng)野生動(dòng)物或野生動(dòng)物群成員的微生物疾病也會被考慮。抗生素耐藥性研究也包括在內(nèi)，前提是研究結(jié)果代表了知識的重大進(jìn)步。強(qiáng)烈建議作者在提交之前閱讀該期刊上先前發(fā)表的社論（“范圍或應(yīng)對”和“范圍或應(yīng)對 II”）。編輯保留建議將他們認(rèn)為更適合該期刊審議的論文提交給其他期刊的權(quán)利。

發(fā)表關(guān)于動(dòng)物微生物疾病的控制、宿主反應(yīng)、分子生物學(xué)、發(fā)病機(jī)制、預(yù)防和治療方面的高質(zhì)量和新穎的原創(chuàng)研究論文。主要涉及免疫學(xué)、流行病學(xué)、分子生物學(xué)和抗病毒或微生物劑的論文只有在證明對疾病有明顯影響時(shí)才會被考慮。僅關(guān)注診斷技術(shù)（例如另一種 PCR 方案或 ELISA）的論文將不予發(fā)表 - 重點(diǎn)應(yīng)放在微生物上，而不是特定技術(shù)上。僅報(bào)告微生物序列、轉(zhuǎn)錄組學(xué)數(shù)據(jù)或蛋白質(zhì)組學(xué)數(shù)據(jù)的論文將不予考慮，除非結(jié)果代表知識的重大進(jìn)步。

如果藥物試驗(yàn)論文具有普遍應(yīng)用或意義，則會考慮它們。關(guān)于微生物鑒定的論文也會被考慮，但詳細(xì)的分類學(xué)研究不屬于該期刊的范圍。病例報(bào)告將不予發(fā)表，除非它們具有普遍應(yīng)用或包含新穎的方面。地理范圍有限的論文，重復(fù)其他地方已確定的內(nèi)容將不予考慮。該期刊的讀者遍布全球。

該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，該刊致力于發(fā)表經(jīng)過嚴(yán)格同行評審的高質(zhì)量原創(chuàng)文章，反映農(nóng)林科學(xué)-獸醫(yī)學(xué)領(lǐng)域的新進(jìn)展、新技術(shù)、新成果，促進(jìn)該領(lǐng)域科研交流和科研成果轉(zhuǎn)化。該刊2023年影響因子為2.4，平均審稿速度為 約3月 約8.1周，近四年來沒有被列入預(yù)警名單。如果您需要投稿發(fā)表服務(wù)及指導(dǎo)，可以聯(lián)系我們的客服老師，我們專業(yè)專注服務(wù)期刊投稿協(xié)助10年，為您提供期刊投稿個(gè)性化定制服務(wù)，并且我們確保嚴(yán)格保密您的個(gè)人信息及稿件內(nèi)容。